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SUMMARY
I
In adult human skin, the expression of the extracellular matrix glycoprotein tenascin is limited. Under hyperproliferative conditions 
such as psoriasis and epidermal tumours, dermal tenascin expression is strongly upregulated. The aim of this study was to investigate 
the pattern and kinetics of tenascin expression in human skin during wound healing and to address the question of whether keratinocytes 
can directly interact with tenascin during re-epithelialization. Tenascin expression was investigated in excisional wounds in normal 
human skin, in explants of normal human skin, and in chronic venous ulcers, using immunohistochemistry. No tenascin staining was 
found directly underneath the leading edge of the sheet of migrating keratinocytes in the excisional wounds and explants. In the 
excisional wounds and the ulcers, dermal tcnascin was strongly upregulated in areas adjacent to hyperproliferative epidermis. These 
hyperproliferative areas are located approximately 10-50 cells behind the leading edge, as assessed by staining for the Ki-67 antigen and 
the proliferating cell nuclear antigen (PCNA). At the later stages of normal wound healing and in the chronic ulcers, tenascin was also 
detected in the wound bed. In these areas, the dermal-epidermal junction stained positive for laminin but was negative for heparan 
sulphate. The absence of the latter basement membrane component suggests that the formation of a new basement membrane is not 
completed in these wounds. These findings suggest that tenascin is not a substrate for migrating keratinocytes; that the rapid induction 
of tenascin expression in the papillary dermis during wound healing results from interaction with the hyperproliferative epidermis; and 
that in the later stages of wound healing, keratinocytes can potentially interact with tenascin in the wound bed, because the basement 
membrane of the neo-epidermis is incomplete.
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INTRODUCTION
Wound healing is characterized by complex changes 
at the inter- and intracellular level, including inflam­
mation, cell migration, and proliferation and reconstruc­
tion of the extracellular matrix (ECM).1' 6 One of the 
ECM molecules whose expression is altered during 
wound healing is tenascin (TN-C).2,3,7~!2 This large 
hexameric glycoprotein was first detected in developing 
embryos, where it was found predominantly at 
epithelial-mesenchymal interaction sites.13“17 In adult 
tissues, expression of tenascin is rather limited. In nor­
mal human skin, tenascin is present in the papillary 
dermis and near the basement membranes surrounding 
blood vessels and epidermal adnexa.12,18,19 We and 
others have shown that the expression of tenascin in the 
papillary dermis of normal skin varies from almost 
absent to a patchwise distribution underneath the 
basement membrane, but is strongly upregulated in 
conditions of epidermal hyperproliferation such as 
psoriasis,18 epidermal tumours, 21 and injury.3,9,22 
Although in vitro studies have suggested various func­
tions for tenascin, including modulation of cell 
adhesion23-28 and the immune response,29,30 its in vivo 
role is still a matter of debate.31
Tenascin expression during wound healing has 
been studied in various animal models.2,3,7,8,1 The
Addressee for correspondence: Joost Schalkwijk, Department of 
Dermatology, University Hospital Nijmegen, P.O. Box 9101, 6500 HB
Nijmegen, The Netherlands.
data on wound healing in humans, however, are quite 
limited: tenascin expression was studied previously in 
surgical wounds,9 chronic venous ulcers,32 and in the 
tape-stripping model for epidermal injury.22 On the 
basis of the findings, it was postulated that tenascin 
might stimulate keratinocyte migration2,7,8,10 and 
that tenascin expression correlates with epidermal 
proliferation.10,22
We now provide new immunohistochemical data on 
the pattern and kinetics of tenascin expression in human 
skin wounds. Experimental excisional wounding of nor­
mal human skin was performed to obtain standardized 
wounds. This experimental set-up allowed the compari­
son of tenascin expression at various stages of wound 
healing in the same subject. Tenascin expression in the 
excisional wounds was compared with expression in 
explant cultures of normal human skin. These explants 
are useful as a model for some aspects of normal wound 
healing, including keratinocyte migration. In addition, 
tenascin expression was investigated in chronic venous 
ulcers, which represent inadequately healing wounds. In 
parallel with the tenascin staining, immunostaining of 
proliferation markers was performed to see whether 
tenascin expression correlates with keratinocyte prolif­
eration, as we suggested previously for hyperprolifera­
tive skin disorders and the tape-stripping model.22 
Finally, heparan sulphate and laminin, two major com­
ponents of basement membranes, were stained to estab­
lish whether during wound healing keratinocytes are 
separated from dermal tenascin by a complete basement 
membrane, as in normal intact skin.
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keratinocytes stained positive for both proliferation 
markers. In all excisional wounds and ulcers, but not in 
the explants, proliferating cells were markedly increased 
compared with normal skin. With respect to the excisional 
wounds, the staining results can be described as follows. 
At days 2,4, and 7, proliferating keratinocytes were rarely 
detected in the neo-epidermis but mainly at some distance 
from the wound margins. An area with almost 100 per 
cent proliferating keratinocytes was located approxi­
mately 10-15 cells away from the leading edge at day 2 . 
This intervening area of 10-15 cells contained about 20 
per cent proliferating cells. The flattened cells of the 
leading edge itself were never Ki-67- or PCNA-positive. 
At days 4 and 7 after wounding, an area with almost 100 
per cent proliferating keratinocytes was separated by 
some 50 cells from the leading edge of migrating 
keratinocytes. Of these 50 cells, approximately 20 per cent 
stained positive. When the wounds were closed, at day 7 
or 14, hyperproliferation at these sites was less pro­
nounced. Basal keratinocytes directly adjacent to the 
former wound margins and in the newly formed epidermis 
had become proliferative instead (Fig. 2b).
In the skin explants, prolifer^ig^rsies; did not alter 
markedly during the 4-day^cultufe period. No PCNA- 
positive cells could be detected in the explants and fewer 
than 5 per cent of the basal cells stained positive for the 
Ki-67 antigen.
In the sections of chronic venous ulcers, PCNA- and 
Ki-67-positive cells were abundant in the basal layers of 
the neo-epidermis and the adjacent epidermis. Consist­
ent with our findings concerning the excisional wound 
model, hyperproliferative areas with 75-100 per cent 
PCNA- or Ki-67-positive keratinocytes were seen at 
some distance from the ulcer edges, typically 50-150 
basal keratinocytes away. In this area, 20-50 per cent of 
the basal keratinocytes were Ki-67- or PCNA-positive, 
(not shown).
Basal membrane staining
Heparan sulphate and laminin were stained to address 
the question of whether keratinocytes are separated 
from dermal tenascin by an intact basement membrane 
during wound healing. Positive staining for heparan 
sulphate was found in the basement membranes of 
normal skin before and after explant culture, and in 
intact skin adjacent to the excisional wounds and the 
ulcers. Remarkably, heparan sulphate staining ceased 
abruptly at the margins of the wounds and the cultured 
biopsies and was never detected under the neo-epidermis 
at any time in any of the models used (Fig. 3b).
The staining pattern of laminin was similar to that of 
heparan sulphate in normal skin and in all the explants, 
but only up to 4 days after wounding in the excisional 
wounds. Seven days after wounding in half of the 
excisional wounds, laminin was detectable beneath the 
migrated keratinocytes near the wound margins, but not 
beneath the leading edge of migrated keratinocytes; in 
the other excisional wounds of day 7, laminin staining 
still resembled heparan sulphate staining. In the 14-day- 
old excisional wounds, laminin was found beneath the 
entire neo-epidermis of all biopsies (Fig. 3c).
In one of five ulcers, the staining pattern of laminin 
resembled that of heparan sulphate. In the other four 
ulcers studied, laminin was detected beneath the entire 
neo-epidermis.
DISCUSSION
We investigated tenascin expression during normal 
and pathological wound healing in vivo and in an in vitro 
model for keratinocyte migration using skin explant 
culturing. The results indicate that tenascin is markedly 
upregulated under all these conditions, but with different 
patterns and kinetics of upregulation. Tenascin is dis- 
continuously distributed near the basement membrane 
in the papillary dermis of normal skin. In contrast, in the 
papillary dermis bordering excisional wounds and 
ulcers, or in the papillary dermis of the original biopsies 
that were used for explant culturing, tenascin continu­
ously lined the basement membrane and to a variable 
extent penetrated more deeply into the dermis. In the 
dermal parts that were covered by migrated keratino­
cytes during wound healing or explant culturing, 
tenascin was clearly detected in all ulcers and explants, 
but only after wound closure in the excisional wounds. 
These data indicate that in chronic venous ulcers, where 
the normal coordination of the wound-healing process is 
lost* the induction of tenascin expression in the wound 
bed does not depend on keratinocyte migration and 
subsequent wound closure. Downregulation of tenascin 
protein to normal levels was not seen in our dynamic 
models, either in excisional wounds that were already 
covered by a multilayered neo-epidermis or in the 
explants in which keratinocytes had enclosed the dermal 
part of the cultured biopsies. This may be due to 
continued production of tenascin or to slow turnover of 
pre-existing tenascin.
A prerequisite for tenascin having a direct in vivo 
effect on keratinocytes, whether it concerns an influence 
on migration, proliferation, or other cellular activities, is 
that keratinocytes can directly interact with tenascin in 
the dermis. In normal intact skin, the basement mem­
brane at the dermal-epidermal junction precludes con­
tact between keratinocytes and tenascin: the size of the 
hexameric tenascin molecules, which in humans is 
approximately 19 00 kD ,34 prevents them from moving 
to the epidermis by diffusion. In this study we have 
shown that during the later stages of normal wound 
healing, tenascin is expressed diffusely in the wound 
bed and that at the same time no heparan sulphate 
is detectable beneath the neo-epidermis covering the 
wound bed. We speculate that in these conditions, 
keratinocytes in the neo-epidermis may interact directly 
with tenascin because no complete basement membrane 
is present. These histological data, however, cannot 
exclude the possibility that a provisional basement mem­
brane, containing laminin and possibly other basement 
membrane components,35 hampers interaction between 
keratinocytes and tenascin. Further studies using 
immunoelectron microscopic analysis of the dermal- 
epidermal junction structures are mandatory to obtain 
more conclusive answers.
TENASCIN in  h e a l in g  s k in  w o u n d s 35
Others have suggested previously that during wound 
healing, keratinocytes migrate over a surface rich in 
tenascin.8 According to our data, tenascin is not a 
substrate for migrating keratinocytes: keratinocyte 
migration precedes tenascin expression both in 
excisional wounds and in skin explants.
Our hypothesis that tenascin upregulation correlates 
with keratinocyte proliferation was partially confirmed 
by the results of this study: at the borders of excisional 
wounds and chronic venous ulcers, tenascin was mark­
edly upregulated in the dermis beneath epidermal hyper- 
proliferative areas. Because at these borders a basement 
membrane is present that separates proliferative kerati­
nocytes from dermal tenascin, a mitogenic effect of 
tenascin in this is not likely. Hyperproliferative kerati­
nocytes, however, may produce a factor that induces 
tenascin expression in the underlying dermis. Candidates 
are the growth factors interleukin-1 (IL-1), tumour 
necrosis factor-a (TNFa), and transforming growth 
factor-/? (TGFyS), which in vitro stimulate tenascin pro­
duction by cultured fibroblasts.36,37 Other aspects of 
cytokine action in wound healing are dealt with at length 
in the review by Slavin in this issue of the journal .38 
Proliferation of keratinocytes, however, appears not to 
be a prerequisite for tenascin upregulation in our in vitro 
model; in the explants, tenascin was clearly upregulated, 
although very few proliferating cells were detected. 
Likewise, inflammation cannot be mandatory for 
tenascin upregulation during explant culture, as the 
explants are excluded from influx of inflammatory cells 
from the blood. Further studies should be directed at 
identifying keratinocyte-derived and other possible 
factors that may regulate dermal tenascin expression 
during wound healing.
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